Thomas Odeny Awarded Clinical Investigator Leadership Award

March 5, 2026

Thomas Odeny, MD, PhD, MPH, member of the Midwest D-CFAR, was recently awarded the prestigious Winn Clinical Investigator Leadership Award (WINN CILA) for Oncology.

Thomas Odeny, MD, PhD, MPH

The Winn CILA is a three-year professional and leadership development program designed for early-career clinical investigators who are graduates of the Winn Career Development Award (Winn CDA). The program provides salary support, advanced clinical trials expertise, high-impact mentorship, and institutional networks to help participants become independent and highly effective community-oriented clinical researchers.

The Winn CILA is one of three awards under the Robert A. Winn Excellence in Clinical Trials Award Program that aims to ensure more patients and communities are included in research and have access to the latest advances in medicine. The Winn Awards were established in 2020 by the Bristol Mysers Squibb Foundation to improve participation in clinical trials to drive better health outcomes in all communities and save more lives.

“We are delighted to witness the growth in leadership skills as well as the strong relationships developed between the Winn CILA-Oncology investigators and their National Clinical Trials Network (NCTN) mentors. Already we have seen progress — expanded networks, patient recruitment, and innovation in clinical trials design,” said Michal Tibbits, Vice President, Professional Development Department, ASCO.

Congratulations, Dr. Odeny, from your colleagues at the Midwest D-CFAR!

Edited by Kate Gershwin.